HEARTS in the Americas: Targeting Health System Change to Improve Population Hypertension Control

Campbell NRC, Ordunez P, Giraldo G, Rodriguez Morales YA, Lombardi C, Khan T, et al. WHO HEARTS: a global program to reduce cardiovascular disease burden: experience implementing in the Americas and opportunities in Canada. Can J Cardiol. 2021;37(5):744–55. https://doi.org/10.1016/j.cjca.2020.12.004.

Article  PubMed  Google Scholar 

Khan T, Moran AE, Perel P, Whelton PK, Brainin M, Feigin V, et al. The HEARTS partner forum-supporting implementation of HEARTS to treat and control hypertension. Front Public Health. 2023;24(11):1146441. https://doi.org/10.3389/fpubh.2023.1146441.

Article  Google Scholar 

Ordunez P, Campbell NRC, Giraldo Arcila GP, Angell SY, Lombardi C, Brettler JW, et al. HEARTS in the Americas: innovations for improving hypertension and cardiovascular disease risk management in primary care. Rev Panam Salud Publica. 2022;16(46):e96. https://doi.org/10.26633/RPSP.2022.96.

Article  Google Scholar 

• Martinez R, Soliz P, Campbell NRC, Lackland DT, Whelton PK, Ordunez P. Association between population hypertension control and ischemic heart disease and stroke mortality in 36 countries of the Americas, 1990–2019: an ecological study. Rev Panam Salud Publica. 2022;16(46):e143. https://doi.org/10.26633/RPSP.2022.143Finding from this study documented a strong ecological negative association between IHD and stroke CVD mortality and population hypertension control. Countries with the best performance in hypertension control showed better progress in reducing CVD mortality.

Article  Google Scholar 

Martinez R, Morsch P, Soliz P, Hommes C, Ordunez P, Vega E. Life expectancy, healthy life expectancy, and burden of disease in older people in the Americas, 1990–2019: a population-based study. Rev Panam Salud Publica. 2021;30(45):e114. https://doi.org/10.26633/RPSP.2021.114.

Article  Google Scholar 

Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010.

Article  PubMed  PubMed Central  Google Scholar 

Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA. 2017;317(2):165–82. https://doi.org/10.1001/jama.2016.19043.Erratum.In:JAMA.2017Feb14;317(6):648. PMID: 28097354.

Article  PubMed  Google Scholar 

NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–980. https://doi.org/10.1016/S0140-6736(21)01330-1. Epub 2021 Aug 24. Erratum in: Lancet. 2022 Feb 5;399(10324):520.

Murphy A, Palafox B, O’Donnell O, Stuckler D, Perel P, AlHabib KF, et al. Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study. Lancet Glob Health. 2018;6(3):e292–301. https://doi.org/10.1016/S2214-109X(18)30031-7.

Article  PubMed  PubMed Central  Google Scholar 

Muntner P, Hardy ST, Fine LJ, Jaeger BC, Wozniak G, Levitan EB, et al. Trends in blood pressure control among US adults with hypertension, 1999–2000 to 2017–2018. JAMA. 2020;324(12):1190–1200. https://doi.org/10.1001/jama.2020.14545.

Leung AA, Williams JVA, McAlister FA, Campbell NRC, Padwal RS; Hypertension Canada’s Research and Evaluation Committee. Worsening hypertension awareness, treatment, and control rates in Canadian women between 2007 and 2017. Can J Cardiol. 2020;36(5):732–739. https://doi.org/10.1016/j.cjca.2020.02.092.

Patel P, Ordunez P, DiPette D, Escobar MC, Hassell T, Wyss F, et al. Standardized hypertension treatment and prevention network. Improved blood pressure control to reduce cardiovascular disease morbidity and mortality: the Standardized Hypertension Treatment and Prevention Project. J Clin Hypertens (Greenwich). 2016;18(12):1284–1294. https://doi.org/10.1111/jch.12861.

Frieden TR, Varghese CV, Kishore SP, Campbell NRC, Moran AE, Padwal R, et al. Scaling up effective treatment of hypertension-a pathfinder for universal health coverage. J Clin Hypertens (Greenwich). 2019;21(10):1442–9. https://doi.org/10.1111/jch.13655.

Article  PubMed  Google Scholar 

Campbell NRC, Schutte AE, Varghese CV, Ordunez P, Zhang XH, Khan T, et al. São Paulo call to action for the prevention and control of high blood pressure: 2020. J Clin Hypertens (Greenwich). 2019;21(12):1744–52. https://doi.org/10.1111/jch.13741.

Article  PubMed  Google Scholar 

Perel P, Avezum A, Huffman M, Pais P, Rodgers A, Vedanthan R, et al. Reducing premature cardiovascular morbidity and mortality in people with atherosclerotic vascular disease: The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease. Glob Heart. 2015;10(2):99–110. https://doi.org/10.1016/j.gheart.2015.04.003.

Article  PubMed  Google Scholar 

Jeemon P, Séverin T, Amodeo C, Balabanova D, Campbell NRC, Gaita D, et al. World heart federation roadmap for hypertension - a 2021 update. Glob Heart. 2021;16(1):63. https://doi.org/10.5334/gh.1066.

Article  PubMed  PubMed Central  Google Scholar 

Campbell NRC, Padwal R, Tsuyuki RT, Leung AA, Bell A, Kaczorowski J, et al. Ups and downs of hypertension control in Canada: critical factors and lessons learned. Rev Panam Salud Publica. 2022;46:e141. https://doi.org/10.26633/RPSP.2022.141.

Jaffe MG, Young JD. The Kaiser Permanente Northern California story: improving hypertension control from 44% to 90% in 13 years (2000 to 2013). J Clin Hypertens (Greenwich). 2016;18(4):260–1. https://doi.org/10.1111/jch.12803.

Article  PubMed  Google Scholar 

Lloyd-Sherlock P, Ebrahim S, Martinez R, McKee M, Ordunez P. Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000–15. Lancet Glob Health. 2019;7(5):e604–12. https://doi.org/10.1016/S2214-109X(19)30069-5.

Article  PubMed  Google Scholar 

Martinez R, Soliz P, Mujica OJ, Reveiz L, Campbell NRC, Ordunez P. The slowdown in the reduction rate of premature mortality from cardiovascular diseases puts the Americas at risk of achieving SDG 3.4: a population trend analysis of 37 countries from 1990 to 2017. J Clin Hypertens (Greenwich). 2020;22(8):1296–1309. https://doi.org/10.1111/jch.13922.

Cooper RS. Control of cardiovascular disease in the 20th century: meeting the challenge of chronic degenerative disease. Perspect Biol Med. 2018;61(4):550–9. https://doi.org/10.1353/pbm.2018.0064.

Article  PubMed  Google Scholar 

Noncommunicable diseases: risk factors [online database], Global Health Observatory (GHO) data. Geneva: World Health Organization; 2023. https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/ncd-risk-factors.

Schwalm JD, Walli-Attaei M, Yusuf S. New approaches needed to improve prevention of cardiovascular disease. JAMA Netw Open. 2023;6(1):e2251162. https://doi.org/10.1001/jamanetworkopen.2022.51162.

Article  CAS  PubMed  Google Scholar 

Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet. 2016;388(10060):2665–712. https://doi.org/10.1016/S0140-6736(16)31134-5.

Article  PubMed  Google Scholar 

World Health Organization & United Nations Children’s Fund (UNICEF). (2020). Operational framework for primary health care: transforming vision into action. World Health Organization. https://apps.who.int/iris/handle/10665/337641. License: CC BY-NC-SA 3.0 IGO.

Sandoval RC, Bacelar Gomes A, Roche M, Parra N, Armada F. Advances in tobacco control in the Region of the Americas, 2020. Rev Panam Salud Publica. 2022;12(46):e202. https://doi.org/10.26633/RPSP.2022.202.

Article  Google Scholar 

Allemandi LA, Flexner N, Nederveen L, Gomes FS. Building capacity in reducing population dietary sodium intake in the Americas. Rev Panam Salud Publica. 2022;46:e198. https://doi.org/10.26633/RPSP.2022.198.

Rincon-Gallardo PS, Constantinou S, Gorlick C, Gomes FS. Evaluating progress and addressing actions to eliminate industrially produced trans-fatty acids in the Americas. Rev Panam Salud Publica. 2022;46:e130. https://doi.org/10.26633/RPSP.2022.130.

Crosbie E, Gomes FS, Olvera J, Rincón-Gallardo Patiño S, Hoeper S, Carriedo A. A policy study on front-of-pack nutrition labeling in the Americas: emerging developments and outcomes. Lancet Reg Health Am. 2022;1(18):100400. https://doi.org/10.1016/j.lana.2022.100400.

Article  Google Scholar 

Champagne BM, Antonio Ochoa E, Khanchandani HS, Schoj V. Civil society’s role in improving hypertension control in Latin America. Rev Panam Salud Publica. 2022;46:e165. https://doi.org/10.26633/RPSP.2022.165.

Guideline for the pharmacological treatment of hypertension in adults [Internet]. Geneva: World Health Organization; 2021. PMID: 34495610.

•• Al-Makki A, DiPette D, Whelton PK, Murad MH, Mustafa RA, Acharya S, et al. Hypertension pharmacological treatment in adults: a World Health Organization guideline executive summary. Hypertension. 2022;79(1):293–301. https://doi.org/10.1161/HYPERTENSIONAHA.121.18192. In these guidelines, the World Health Organization provides the most current and relevant evidence-based guidance for the pharmacological treatment of nonpregnant adults with hypertension.

Article  CAS  PubMed  Google Scholar 

Sosa Liprandi A, Baranchuk A, López-Santi R, Wyss F, Piskorz D, Puente A, et al. El control de la hipertensión arterial, una asignatura pendiente. Rev Panam Salud Publica. 2022;46:e147. https://doi.org/10.26633/RPSP.2022.147.

Jaffe MG, DiPette DJ, Campbell NRC, Angell SY, Ordunez P. Developing population-based hypertension control programs. Rev Panam Salud Publica. 2022;15(46):e153. https://doi.org/10.26633/RPSP.2022.153.

Article  Google Scholar 

Organización Panamericana de la Salud. Síntesis de evidencia y recomendaciones: directrices para el tratamiento farmacológico de la hipertensión arterial en adultos. Rev Panam Salud Publica. 2022;46:e172. https://doi.org/10.26633/RPSP.2022.172.

Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–115. https://doi.org/10.1161/HYP.0000000000000065.

Article  CAS  PubMed  Google Scholar 

Mancia G, Kreutz, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens. 2023 Jun 21. https://doi.org/10.1097/HJH.0000000000003480.

Campbell NRC, Paccot Burnens M, Whelton PK, Angell SY, Jaffe MG, Cohn J, et al. 2021 World Health Organization guideline on pharmacological treatment of hypertension: policy implications for the region of the Americas. Lancet Reg Health Am. 2022. https://doi.org/10.1016/j.lana.2022.100219.

Rosende A, DiPette D, Brettler J, Rodríguez G, Zuniga E, Connell K, et al. HEARTS in the Americas appraisal checklist and clinical pathway for comprehensive hypertension management in primary care. Rev Panam Salud Publica. 2022;2(46):e125. https://doi.org/10.26633/RPSP.2022.125.

Article  Google Scholar 

Brettler JW, Arcila GPG, Aumala T, Best A, Campbell NR, Cyr S, et al. Drivers and scorecards to improve hypertension control in primary care practice: recommendations from the HEARTS in the Americas Innovation Group. Lancet Reg Health Am. 2022. https://doi.org/10.1016/j.lana.2022.100223.

HEARTS Technical package for cardiovascular disease management in primary health care: evidence-based treatment protocols. Geneva: World Health Organization; 2018 (WHO/NMH/NVI/18.2). Licence: CC BY-NC-SA 3.0 IGO.

Cheung AK, Whelton PK, Muntner P, Schutte AE, Moran AE, Williams B, et al. International consensus on standardized clinic blood pressure measurement – a call to action. Am J Med. 2023;136(5):438–445.e1. https://doi.org/10.1016/j.amjmed.2022.12.015.

Article  PubMed  Google Scholar 

Ordunez P, Lombardi C, Picone DS, Brady TM, Campbell NRC, Moran AE, et al. HEARTS in the Americas: a global example of using clinically validated automated blood pressure devices in cardiovascular disease prevention and management in primary health care settings. J Hum Hypertens. 2023;37(2):126–9. https://doi.org/10.1038/s41371-022-00659-z.

Article  PubMed  Google Scholar 

Campbell NRC, Khalsa T, Ordunez P, Rodriguez Morales YA, Zhang XH, Parati G, et al. Brief online certification course for measuring blood pressure with an automated blood pressure device. A free new resource to support World Hypertension Day Oct 17, 2020. J Clin Hypertens (Greenwich). 2020;22(10):1754–1756. https://doi.org/10.1111/jch.14017.

HEARTS in the Americas Regulatory Pathway to the Exclusive Use of Validated Blood Pressure Measuring Devices. Washington, D.C.: Pan American Health Organization; 2021. License: CC BY-NC-SA 3.0 IGO. https://doi.org/10.37774/9789275124864.

Flood D, Edwards EW, Giovannini D, Ridley E, Rosende A, Herman WH, et al. Integrating hypertension and diabetes management in primary health care settings: HEARTS as a tool. Rev Panam Salud Publica. 2022;2(46):e150. https://doi.org/10.26633/RPSP.2022.150.Erratum.In:RevPanamSaludPublica.2022Nov30;46:e206.47.

Article  Google Scholar 

Rosende A, DiPette DJ, Martinez R, Brettler JW, Rodriguez G, Zuniga E, et al. HEARTS in the Americas clinical pathway. Strengthening the decision support system to improve hypertension and cardiovascular disease risk management in primary care settings. Front Cardiovasc Med. 2023;10:1102482. https://doi.org/10.3389/fcvm.2023.1102482.

Ordunez P, Tajer C, Gaziano T, Rodriguez YA, Rosende A, Jaffe MG. The HEARTS app: a clinical tool for cardiovascular risk and hypertension management in primary health care. Rev Panam Salud Publica. 2022;28(46):e12. https://doi.org/10.26633/RPSP.2022.12.

Article  Google Scholar 

HEARTS. Cardiovascular Risk Calculator App. [cited 2023 Aug 16]. Available from: https://www.paho.org/en/hearts-americas/cardiovascular-risk-calculator-app.

WHO CVD Risk Chart Working Group. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health. 2019 Oct;7(10):e1332-e1345. https://doi.org/10.1016/S2214-109X(19)30318-3. Epub 2019 Sep 2. Erratum in: Lancet Glob Health. 2023;11(2):e196.

DiPette DJ, Goughnour K, Zuniga E, Sk

留言 (0)

沒有登入
gif